112091-27-7 Usage
Uses
Used in Chemical Synthesis:
ETHYL 2-CHLORO-2-[2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO]ACETATE is used as an intermediate or reagent in chemical synthesis processes for the production of various compounds. Its unique structure allows for specific reactions and transformations that can be utilized in the synthesis of target molecules.
Used in Pharmaceutical Industry:
ETHYL 2-CHLORO-2-[2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO]ACETATE is used as a building block or precursor in the development of pharmaceutical compounds. Its complex structure may contribute to the creation of new drugs with potential therapeutic applications, although further research and development would be necessary to determine its suitability and effectiveness in this context.
Used in Research and Development:
ETHYL 2-CHLORO-2-[2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO]ACETATE is used as a research compound in academic and industrial laboratories. Its unique properties and potential reactivity make it a valuable tool for studying chemical reactions, mechanisms, and the development of new synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 112091-27-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,0,9 and 1 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 112091-27:
(8*1)+(7*1)+(6*2)+(5*0)+(4*9)+(3*1)+(2*2)+(1*7)=77
77 % 10 = 7
So 112091-27-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H9Cl2N3O4/c1-2-19-10(16)9(12)14-13-7-4-3-6(11)5-8(7)15(17)18/h3-5,13H,2H2,1H3/b14-9+
112091-27-7Relevant academic research and scientific papers
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: Synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substitued derivatives
Catarzi, Daniela,Colotta, Vittoria,Varano, Flavia,Lenzi, Ombretta,Filacchioni, Guido,Trincavelli, Letizia,Martini, Claudia,Montopoli, Christian,Moro, Stefano
, p. 7932 - 7945 (2007/10/03)
A number of 4-oxo-substituted 1,2,4-triazolo[1,5-a]quinoxaline derivatives bearing at position-2 the claimed (hetero)aryl moiety (compounds 1-15) but also a carboxylate group (16-28, 32-36) or a hydrogen atom (29-31) were designed as human A3 (
